Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07128186

The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

The objective of this observational study is to evaluate the accuracy and feasibility of an artificial intelligence-based multimodal cognitive screening system in early identification of diabetes-related mild cognitive impairment (MCI) among type 2 diabetes mellitus (T2DM) patients through a 3-5 year follow-up. It also aims to analyze the correlation between diabetic metabolic indicators (such as glycemic variability and HbA1c levels) and cognitive function changes, thereby determining the value of this intelligent screening system in early detection and intervention of cognitive impairment in T2DM patients, which constitutes the key focus of this research.

Conditions

Interventions

TypeNameDescription
OTHERfollow-up observationIn this study, no additional interventions were administered to any enrolled participants; only 3-5 years of follow-up observation were conducted, with cognitive status data collected at both baseline and endpoint.

Timeline

Start date
2025-04-22
Primary completion
2028-12-30
Completion
2028-12-30
First posted
2025-08-17
Last updated
2025-08-17

Locations

21 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07128186. Inclusion in this directory is not an endorsement.